ArticleFrontiers in cardiovascular medicine2025
A nomogram model in elderly patients with coronary heart disease for predicting prognosis: research based on a real-world registry in China.
Article in Frontiers in cardiovascular medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: Coronary heart disease (CHD) is closely associated with aging and has become the leading cause of death in the elderly (≥65 years). This study aimed to identify independent risk factors for 2-year major adverse cardiovascular and cerebrovascular events (MACCE) in elderly patients with CHD, construct a nomogram model for predicting MACCE risk, and validate its performance to assist in identifying high-risk patients and optimizing secondary prevention strategies. Methods: Patients aged ≥65 years diagnosed with CHD were included. The primary outcome of the study was MACCE. The secondary outcomes included cardiovascular death and cardiovascular readmission. A nomogram model was constructed. Patients were divided into low-risk, medium-risk, and high-risk groups according to the tertiles of the nomogram model scores, and the primary and secondary outcomes of patients with different risks were compared. Results: This study finally included 8,340 elderly patients with CHD. MACCE occurred in 523 patients during the follow-up period, with an incidence rate of 6.3%. The Least Absolute Shrinkage and Selection Operator (LASSO) regression method was used to screen 11 independent factors associated with MACCE within 2 years. The model had a good predictive value for MACCE, with a C-statistic of 0.765 (95% CI: 0.743-0.788). The MACCE rates ranged from low risk 1.6%, medium risk 4.2% to high risk 12.6%, indicating that the nomogram model can effectively distinguish high risk patients (Log-rank Conclusion: The established MACCE risk nomogram prediction model for elderly patients with CHD could effectively identify high-risk elderly patients with CHD.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.